Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.
作者信息
Paolino Giovanni, Di Nicola Matteo Riccardo, Cantisani Carmen, Mercuri Santo Raffaele
机构信息
Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
Dermatologic Clinic, Sapienza University of Rome, Rome, Italy.
出版信息
Dermatol Ther. 2021 Jul;34(4):e14972. doi: 10.1111/dth.14972. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.一名新冠病毒肺炎患者通过远程医疗成功使用全身性类固醇和抗组胺药治疗玫瑰糠疹感染：关于潜在的严重急性呼吸综合征冠状病毒2感染可能前驱症状的文献综述
Dermatol Ther. 2021 Jul;34(4):e14972. doi: 10.1111/dth.14972. Epub 2021 May 24.
2
Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.玫瑰糠疹继发于 SARS-CoV-2 感染：一例报告。
Medicine (Baltimore). 2021 Apr 9;100(14):e25352. doi: 10.1097/MD.0000000000025352.
3
Pityriasis rosea after mRNA COVID-19 vaccination.新型冠状病毒肺炎mRNA疫苗接种后玫瑰糠疹
Int J Dermatol. 2021 Sep;60(9):1150-1151. doi: 10.1111/ijd.15700. Epub 2021 Jun 10.
4
Pityriasis rosea following SARS-CoV-2 vaccination: A case series.新型冠状病毒2型疫苗接种后玫瑰糠疹：病例系列
J Cosmet Dermatol. 2021 Oct;20(10):3080-3084. doi: 10.1111/jocd.14372. Epub 2021 Aug 7.
5
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.HHV-6 感染在 COVID-19 大流行中的临床特征：玫瑰糠疹和川崎病。
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
6
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.mRNA-1273 COVID-19疫苗接种后不久出现玫瑰糠疹
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
7
Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.科兴新冠疫苗接种后玫瑰糠疹：一例报告
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e491-e493. doi: 10.1111/jdv.17316. Epub 2021 May 10.
8
Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19.玫瑰糠疹作为接种新冠疫苗可能出现的并发症。
Dtsch Arztebl Int. 2021 Jun 25;118(25):431. doi: 10.3238/arztebl.m2021.0257.
9
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.新冠病毒玫瑰糠疹样和荨麻疹样皮疹中严重急性呼吸综合征冠状病毒2刺突蛋白阳性
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
10
Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.玫瑰糠疹、新冠病毒肺炎与疫苗接种：解读老相识的新线索
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e489-e491. doi: 10.1111/jdv.17301. Epub 2021 May 12.
引用本文的文献
1
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea.超越母斑：探索玫瑰糠疹的复杂全貌
Am J Clin Dermatol. 2025 Mar;26(2):237-250. doi: 10.1007/s40257-024-00915-7. Epub 2025 Jan 11.
2
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
3
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.玫瑰糠疹与SARS-CoV-2/COVID-19感染及疫苗接种的综述
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
4
Cutaneous Reactions to COVID-19 Vaccines in a Monocentric Study: A Case Series.单中心研究中 COVID-19 疫苗的皮肤反应：病例系列
J Clin Med. 2022 Jun 30;11(13):3811. doi: 10.3390/jcm11133811.
5
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.新型冠状病毒病 2019 与玫瑰糠疹：免疫关联的综述。
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
本文引用的文献
1
Pityriasis rosea as a leading manifestation of COVID-19 infection.玫瑰糠疹作为新型冠状病毒肺炎感染的主要表现。
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e246-e247. doi: 10.1111/jdv.17052. Epub 2020 Dec 23.
2
Pityriasis rosea-like eruption revealing COVID-19.玫瑰糠疹样皮疹揭示新型冠状病毒肺炎
Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504. Epub 2020 Nov 20.
3
Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases.确诊为COVID-19阳性但无其他症状的玫瑰糠疹患者：2例报告。
JAAD Case Rep. 2021 Jan;7:93-94. doi: 10.1016/j.jdcr.2020.10.035. Epub 2020 Nov 7.
4
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.新型冠状病毒肺炎期间玫瑰糠疹患者中人类疱疹病毒6型、7型及EB病毒的激活情况
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
5
Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.一名新冠病毒检测呈阳性的无症状患者出现了吉伯特型玫瑰糠疹皮疹。
Med Clin (Engl Ed). 2020 Sep 25;155(6):273. doi: 10.1016/j.medcle.2020.05.017. Epub 2020 Sep 4.
6
Prolonged dermatological manifestation 4 weeks following recovery of COVID-19 in a child.一名儿童在新冠病毒病康复4周后出现长期皮肤表现。
BMJ Case Rep. 2020 Aug 11;13(8):e237056. doi: 10.1136/bcr-2020-237056.
7
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.HHV-6 感染在 COVID-19 大流行中的临床特征：玫瑰糠疹和川崎病。
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
8
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.玫瑰糠疹作为新型冠状病毒肺炎感染的一种皮肤表现。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
Zotero 插件